DCL: Explanation for consolidated business result in QII/2012

Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO) explained the fluctuation in consolidated profit in Quarter II/2012 compared to Quarter II/2011 as follows:

- Consolidated profit after tax in Quarter II/2012: -VND11,745,881,746

- Consolidated profit after tax in Quarter II/2011: -VND32,131,575,942

      The consolidated profit after tax in Quarter II/2012 increased by VND33,533,449,280 (equivalent to 10%) compared to the consolidated profit after tax in Quarter II/2011 because

Financial expenses in Quarter 2/2012 was VND17.194 billion, decreasing VND3.3 billion compared to in Quarter 2/2011, mainly because interest expenses went down.

      Selling expenses in Quarter 2/2012 decreased VND15.839 billion because the company changes of sales policy.

      Therefore, profit after tax in Quarter 2/2012 was higher than in Quarter 2/2011.

HOSE

>   CMV: Explanation for business result in Q2.2012 (21/08/2012)

>   AMV: Reviewed financial statement 2012 (21/08/2012)

>   BTH: Reviewed financial statement 2012 (21/08/2012)

>   GMX: Delay in submitting financial statement refused (21/08/2012)

>   PXM: Explanation for business results in quarter 2/2012 (21/08/2012)

>   KMR: Explanation for business result in Q2.2012 (21/08/2012)

>   MDG: Explanation for business results in quarter 2.2012 (21/08/2012)

>   VTB: VTB reminded to submit financial statements (21/08/2012)

>   GIL: Explanation for consolidated financial statements in Q2.2012 (21/08/2012)

>   LHG: Extension for submission of reviewed semi-annual financial statements Q2.2012 (21/08/2012)